Cardiovascular

With decades of experience across various organizations, ClinDatrix staff bring great expertise in conducting clinical trials spanning all phases (I-III). Our extensive research includes pivotal studies on the prevention of myocardial infarction (MI) and stroke, HIV cardiovascular risk reduction, bifurcated stent grafts with five-year follow-up, endovascular aneurysms, abdominal aortic aneurysms, coronary artery disease, transmyocardial revascularization, and blood loss monitoring.

We have successfully designed electronic data capture (EDC) databases for intricate protocols related to these cardiovascular diseases. Our proficiency in electronic case report form design, protocol refinement, and clinical trial logistics positions ClinDatrix as a leader in cardiovascular clinical trials.

Key Highlights of ClinDatrix Cardiovascular Expertise:

• Agility in Study Management: Our study database launch capabilities enable deployment on our own servers within 5 weeks—significantly faster than the industry standard of 12 weeks—along with protocol adjustments made within 1-2 days instead of weeks.
• Experienced Team: ClinDatrix’s cardiovascular teams average 20 years of experience in the field, ensuring high-level execution and strategic guidance throughout all phases of clinical trials.
• Regulatory Expertise: We have a proven track record of adhering to industry standards and regulatory requirements, ensuring compliance throughout the study process.

ClinDatrix’s comprehensive support guarantees that sponsors achieve their study objectives with precision, bolstered by our commitment to operational excellence and scientific rigor.

Contact ClinDatrix today to discover how our cardiovascular study services can elevate your research initiatives.

ClinDatrix Cardiovascular Studies:

Service Codes

• BI = Biostatistics
• CL = Clinical
• DM = Data Management
• FS = Full Service
• MS = Medical Safety
• MW = Medical Writing
• RA = Regulatory Affairs